Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
about
Soy food intake and breast cancer survivalBiochanin A, a naturally occurring inhibitor of fatty acid amide hydrolaseOverlapping but distinct effects of genistein and ethinyl estradiol (EE(2)) in female Sprague-Dawley rats in multigenerational reproductive and chronic toxicity studiesBiochanin A Modulates Cell Viability, Invasion, and Growth Promoting Signaling Pathways in HER-2-Positive Breast Cancer Cells.Brief telephone intervention increases soy intake in peri- and postmenopausal US women: the Herbal Alternatives Trial (HALT)Isoflavones - Mechanism of Action and Impact on Breast Cancer RiskThe role of soy in vegetarian dietsIsoflavonoids - an overview of their biological activities and potential health benefits.Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapyPhytoestrogens in postmenopause: the state of the art from a chemical, pharmacological and regulatory perspectiveSoy isoflavone phase II metabolism differs between rodents and humans: implications for the effect on breast cancer riskCurrent knowledge and future direction of research on soy isoflavones as a therapeutic agentsToxicological aspects of the use of phenolic compounds in disease prevention.Urinary isoflavonoids and risk of type 2 diabetes: a prospective investigation in US women.Development of an updated phytoestrogen database for use with the SWAN food frequency questionnaire: intakes and food sources in a community-based, multiethnic cohort studyPrevalence, sources, and predictors of soy consumption in breast cancer.Bone sparing effect of a novel phytoestrogen diarylheptanoid from Curcuma comosa Roxb. in ovariectomized rats.Harnessing the fruits of nature for the development of multi-targeted cancer therapeutics.Pueraria mirifica Exerts Estrogenic Effects in the Mammary Gland and Uterus and Promotes Mammary Carcinogenesis in Donryu RatsThe soy isoflavones for reducing bone loss (SIRBL) study: a 3-y randomized controlled trial in postmenopausal women.Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohortsCoexposure to phytoestrogens and bisphenol a mimics estrogenic effects in an additive mannerA brief historical overview of the past two decades of soy and isoflavone research.Can breast cancer patients use soyafoods to help reduce risk of CHD?Soy protein extract (SPE) exhibits differential in vitro cell proliferation effects in oral cancer and normal cell lines.Effectiveness of red clover in alleviating menopausal symptoms: a 12-week randomized, controlled trial.Effect of dietary soy intake on breast cancer risk according to menopause and hormone receptor status.Epidemiological Evidences on Dietary Flavonoids and Breast Cancer Risk: A Narrative ReviewSoy, Soy Foods and Their Role in Vegetarian Diets.The phytoestrogens daidzein and equol inhibit the drug transporter BCRP/ABCG2 in breast cancer cells: potential chemosensitizing effect.Intake of Individual Flavonoids and Risk of Carcinogenesis: Overview of Epidemiological Evidence.Soy isoflavone attenuates brain mitochondrial oxidative stress induced by β-amyloid peptides 1-42 injection in lateral cerebral ventricle.In vitro screening and isolation of human aromatase inhibitors from Cicer arietinum by a novel continuous online method combining chromatographic techniques.Activity of isoflavones and berberine on vasomotor symptoms and lipid profile in menopausal women.Improved protein quality in transgenic soybean expressing a de novo synthetic protein, MB-16.Detecting the QTL-allele system of seed isoflavone content in Chinese soybean landrace population for optimal cross design and gene system exploration.Effects of the Hormone Replacement Therapy and of Soy Isoflavones on Bone Resorption in Postmenopause
P2860
Q24609611-73A97874-3F62-4D72-94A2-D3A6D63A437FQ24620186-660EF784-0BA6-4C6F-8FAE-A5C0D9D588F6Q28389598-55FDBE4D-A29C-4AD5-BE0C-0C52E53A6D06Q33652374-50C90529-4894-432A-8025-D890879BD257Q34116673-DF53BBEB-E2F0-4D04-893F-32413AA9911EQ34140151-4A6BE91C-DE6B-4C2C-828C-0F7F2904CC76Q34247970-E6944F43-6127-4124-B357-EA7035023DE4Q34320079-0598DF0E-0DE5-4768-AE44-6ACD7B048436Q34334503-005E1AD3-12A4-40B1-8BCD-0E2E5C5068A1Q34380530-9CCBCE41-9C11-4AE1-ABA3-7A0FFAA0A4A3Q35335557-2A0C3B64-91C2-4D96-8A24-B70BB935815AQ35646728-1AE0FA60-630B-4E9E-B604-9E11866235ADQ35743072-B84A2790-DEE8-44A4-998A-F4DB4E35298AQ36604298-00447A9A-7712-48A5-93DC-E7CCF8E3165AQ36908475-FAFCDDF7-538B-4545-99A9-6B60625E1665Q37077704-C2A28BD0-0F95-49CF-AFB6-117132111813Q37297768-E931C2E3-A01F-4BCB-A7DF-783E1AC31A37Q37442309-DC704F98-7D93-482B-8B52-3FBD4FE05000Q37450345-BA129DDE-1245-4C2A-BA8C-344CB0698D26Q37474722-F7D7E85D-DF94-4606-B907-17AAA17A8EBEQ37482267-080AC37D-7DB5-40CC-A588-6B7058C553C7Q37595210-C6E6156C-5FBC-4450-B9D2-4321A55912ADQ37756426-2217AAA3-E94B-482E-AFF9-2AAEF52B427AQ38032972-EDF4B421-F025-4D55-B814-849D3B9026BBQ39376475-78CEA655-A546-4674-9381-726D59AF0222Q41592746-D3F690DC-BAE1-4621-AEB6-3ACBF9A99CD5Q43008372-B37D4A50-B788-4BF6-A411-3F29F4E0236CQ47137099-5D33AD9D-E60F-408E-9618-191C42ACCA83Q47230001-A405FF01-0E82-40D9-BF6C-0DB19927990DQ47442621-8FDCB1AD-9E4F-450F-8D86-DD73979545B2Q47692407-F8A11EA8-A022-46C5-9912-766001BDD29DQ48253818-40142831-CFC8-458D-AFA6-171ADDF6EF36Q48344749-CDC0FE9C-9C20-4A75-8D8F-BA2ED34AE1FDQ48486547-C2C5E6A6-DF7B-464E-ABBC-66AB14855019Q50463516-4780B503-1EE5-4FF3-969E-9A27D5615CD3Q50852337-9E81848A-DECD-42A7-BEA5-6CA390715BDEQ58702579-FEC8A3C6-99C9-4B93-8F64-4E650F8EFAAB
P2860
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@ast
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@en
type
label
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@ast
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@en
prefLabel
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@ast
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@en
P2860
P921
P356
P1433
P1476
Soy isoflavones, estrogen therapy, and breast cancer risk: analysis and commentary.
@en
P2093
Charles E Wood
Mark J Messina
P2860
P2888
P356
10.1186/1475-2891-7-17
P5008
P577
2008-06-03T00:00:00Z
P5875
P6179
1047545561